Opinion
Video
Author(s):
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
TILs May Guide Treatment De-Escalation in ERBB2-Positive Breast Cancer
Rising Breast Cancer Rates Show Disparities Across Racial, Ethnic Groups in the US